LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 140 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.21 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $310,000 | -13.4% | 36,202 | 0.0% | 0.01% | -12.5% |
| Q4 2017 | $358,000 | -19.6% | 36,202 | 0.0% | 0.01% | -20.0% |
| Q3 2017 | $445,000 | -25.3% | 36,202 | 0.0% | 0.01% | -23.1% |
| Q2 2017 | $596,000 | +14.8% | 36,202 | 0.0% | 0.01% | +8.3% |
| Q1 2017 | $519,000 | – | 36,202 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $62,009,000 | 100.00% |
| Artal Group S.A. | 57,517,977 | $825,383,000 | 17.04% |
| NEA Management Company, LLC | 2,382,286 | $34,186,000 | 1.77% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $512,000 | 1.49% |
| BRIDGER MANAGEMENT, LLC | 1,029,926 | $14,779,000 | 0.95% |
| FALCON POINT CAPITAL, LLC | 287,809 | $4,130,000 | 0.71% |
| HANCOCK WHITNEY CORP | 664,025 | $9,529,000 | 0.40% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 494,380 | $7,094,000 | 0.39% |
| ELLINGTON MANAGEMENT GROUP LLC | 11,700 | $168,000 | 0.23% |
| Convergence Investment Partners, LLC | 114,157 | $1,638,000 | 0.22% |